Skip to main content
Top
Published in: BMC Psychiatry 1/2017

Open Access 01-12-2017 | Research article

QLiS-SF: Development of a short form of the quality of life in schizophrenia questionnaire

Authors: T. Senin, M. Franz, M. Deuschle, N. Bergemann, J. Kammerer-Ciernioch, M. Lautenschlager, T. Meyer

Published in: BMC Psychiatry | Issue 1/2017

Login to get access

Abstract

Background

There is a need for useful standardized Quality of Life (QoL) measures for people diagnosed with schizophrenia. Therefore, a short form of the self-administered Quality of Life in Schizophrenia (QLiS) scale was developed and validated.

Methods

Four steps were taken to develop the abridged version using samples from the Clinical Analysis of the Treatment of Schizophrenia (CATS) study. Firstly, a model with second order scales was developed using exploratory factor analysis (EFA). Secondly, it was tested in an independent sample using confirmatory factor analysis (CFA). Thirdly, this model served as the basis for selecting items for the short form. Distributional properties, content reviews, and factor loadings were taken into account in this step. Fourthly, the resulting short form was validated through confirmatory factor analysis (CFA). Composite reliability scores were calculated for the new subscales.

Results

Three second order scales were constructed: illness-related quality of life (QoL), social life and finances, and global subjective well-being. CFA of the new theoretical model resulted in a CFI of 0.67 and absolute fit indices of CMIN/df = 2.55, RMSEA = 0.08, SRMR = 0.09. The selected 13 items showed good statistical properties and good fit of content to subscale. Fit of the underlying theoretical model with the reduced number of items was tested in an independent sample. Absolute and fit indices of the short form model were satisfactory (CFI = 0.95, CMIN/df = 2.23, RMSEA = 0.06, SRMR = 0.04). Composite reliability scores for three subscales were above 0.70.

Conclusions

The short form of the QLIS (QLiS-SF) showed good model fit and reliability. It should only be considered for use if the application of the long version is not suitable.
Appendix
Available only for authorised users
Literature
2.
go back to reference Hofer A, Baumgartner S, Edlinger M, Hummer M, Kemmler G, Rettenbacher MA, Schweigkofler H, Schwitzer J, Fleischhacker WW. Patient outcomes in schizophrenia I: correlates with sociodemographic variables, psychopathology, and side effects. Eur. Psychiatry. 2005;20:386–94.CrossRefPubMed Hofer A, Baumgartner S, Edlinger M, Hummer M, Kemmler G, Rettenbacher MA, Schweigkofler H, Schwitzer J, Fleischhacker WW. Patient outcomes in schizophrenia I: correlates with sociodemographic variables, psychopathology, and side effects. Eur. Psychiatry. 2005;20:386–94.CrossRefPubMed
3.
go back to reference Hofer A, Baumgartner S, Bodner T, Edlinger M, Hummer M, Kemmler G, Rettenbacher MA, Fleischhacker WW. Patient outcomes in schizophrenia II: the impact of cognition. Eur. Psychiatry. 2005;20:395–402.CrossRefPubMed Hofer A, Baumgartner S, Bodner T, Edlinger M, Hummer M, Kemmler G, Rettenbacher MA, Fleischhacker WW. Patient outcomes in schizophrenia II: the impact of cognition. Eur. Psychiatry. 2005;20:395–402.CrossRefPubMed
4.
go back to reference Karow A, Wittmann L, Schöttle D, Schäfer I, Lambert M. The assessment of quality of life in clinical practice in patients with schizophrenia. Dialogues Clin Neurosci. 2014;16:185–95.PubMedPubMedCentral Karow A, Wittmann L, Schöttle D, Schäfer I, Lambert M. The assessment of quality of life in clinical practice in patients with schizophrenia. Dialogues Clin Neurosci. 2014;16:185–95.PubMedPubMedCentral
5.
go back to reference Bobes J, García-Portilla P, Sáiz PA, Bascarán T, Bousoño M. Quality of life measures in schizophrenia. Eur. Psychiatry. 2005;20:S313.CrossRefPubMed Bobes J, García-Portilla P, Sáiz PA, Bascarán T, Bousoño M. Quality of life measures in schizophrenia. Eur. Psychiatry. 2005;20:S313.CrossRefPubMed
6.
go back to reference Franz M, Fritz M, Meyer T. Discriminant and convergent validity of a subjective quality-of-life instrument aimed at high content validity for schizophrenic persons. Qual Life Res Int J Qual Life Asp Treat Care Rehab. 2013;22:1113–22.CrossRef Franz M, Fritz M, Meyer T. Discriminant and convergent validity of a subjective quality-of-life instrument aimed at high content validity for schizophrenic persons. Qual Life Res Int J Qual Life Asp Treat Care Rehab. 2013;22:1113–22.CrossRef
8.
go back to reference Hayhurst KP, Massie JA, Dunn G, Lewis SW, Drake RJ. Validity of subjective versus objective quality of life assessment in people with schizophrenia. BMC Psychiatry. 2014;14:365.CrossRefPubMedPubMedCentral Hayhurst KP, Massie JA, Dunn G, Lewis SW, Drake RJ. Validity of subjective versus objective quality of life assessment in people with schizophrenia. BMC Psychiatry. 2014;14:365.CrossRefPubMedPubMedCentral
9.
go back to reference The WHOQOL Group. Development of the World Health Organization WHOQOL-BREF quality of life assessment. The WHOQOL group. Psychol Med. 1998;28:551–8.CrossRef The WHOQOL Group. Development of the World Health Organization WHOQOL-BREF quality of life assessment. The WHOQOL group. Psychol Med. 1998;28:551–8.CrossRef
10.
11.
go back to reference Wiebe S, Guyatt G, Weaver B, Matijevic S, Sidwell C. Comparative responsiveness of generic and specific quality-of-life instruments. J Clin Epidemiol. 2003;56:52–60.CrossRefPubMed Wiebe S, Guyatt G, Weaver B, Matijevic S, Sidwell C. Comparative responsiveness of generic and specific quality-of-life instruments. J Clin Epidemiol. 2003;56:52–60.CrossRefPubMed
12.
go back to reference Świtaj P, Anczewska M, Chrostek A, Sabariego C, Cieza A, Bickenbach J, Chatterji S. Disability and schizophrenia: a systematic review of experienced psychosocial difficulties. BMC Psychiatry. 2012;12:193.CrossRefPubMedPubMedCentral Świtaj P, Anczewska M, Chrostek A, Sabariego C, Cieza A, Bickenbach J, Chatterji S. Disability and schizophrenia: a systematic review of experienced psychosocial difficulties. BMC Psychiatry. 2012;12:193.CrossRefPubMedPubMedCentral
13.
go back to reference Awad AG. Quality-of-life assessment in schizophrenia: the unfulfilled promise. Expert Rev. Pharmacoecon. Outcomes Res. 2011;11:491–3.CrossRefPubMed Awad AG. Quality-of-life assessment in schizophrenia: the unfulfilled promise. Expert Rev. Pharmacoecon. Outcomes Res. 2011;11:491–3.CrossRefPubMed
14.
go back to reference Boyer L, Baumstarck K, Boucekine M, Blanc J, Lançon C, Auquier P. Measuring quality of life in patients with schizophrenia: an overview. Expert Rev Pharmacoecon Outcomes Res. 2013;13:343–9.CrossRefPubMed Boyer L, Baumstarck K, Boucekine M, Blanc J, Lançon C, Auquier P. Measuring quality of life in patients with schizophrenia: an overview. Expert Rev Pharmacoecon Outcomes Res. 2013;13:343–9.CrossRefPubMed
15.
go back to reference Morris J, Perez D, McNoe B. The use of quality of life data in clinical practice. Qual Life Res. 1997;7:85–91.CrossRef Morris J, Perez D, McNoe B. The use of quality of life data in clinical practice. Qual Life Res. 1997;7:85–91.CrossRef
16.
go back to reference Deuschle M, Bergemann N, Kammerer-Ciernioch J, Franz M, Lautenschlager M, Lederbogen F, Weisbrod M, Brosz M, Reichmann J, Umbreit J. Clinical analyses of the treatment of schizophrenia, CATS. Grundlagen einer pharmakologischen Studie zur Qualität der Versorgung von Patienten mit Schizophrenie. Psychopharmakotherapie. 2008;15:147–52. Deuschle M, Bergemann N, Kammerer-Ciernioch J, Franz M, Lautenschlager M, Lederbogen F, Weisbrod M, Brosz M, Reichmann J, Umbreit J. Clinical analyses of the treatment of schizophrenia, CATS. Grundlagen einer pharmakologischen Studie zur Qualität der Versorgung von Patienten mit Schizophrenie. Psychopharmakotherapie. 2008;15:147–52.
17.
go back to reference Deuschle M, Paul F, Brosz M, Bergemann N, Franz M, Kammerer-Ciernioch J, Lautenschlager M, Lederbogen F, Roesch-Ely D, Weisbrod M, Kahl KG, Reichmann J, Gross J, Umbreit J. Assessment of cardiovascular disease risk in patients with schizophrenia spectrum disorders in German psychiatric hospitals: results of the pharmacoepidemiologic CATS study. Soc Psychiatry Psychiatr Epidemiol. 2013;48:1283–8.CrossRefPubMed Deuschle M, Paul F, Brosz M, Bergemann N, Franz M, Kammerer-Ciernioch J, Lautenschlager M, Lederbogen F, Roesch-Ely D, Weisbrod M, Kahl KG, Reichmann J, Gross J, Umbreit J. Assessment of cardiovascular disease risk in patients with schizophrenia spectrum disorders in German psychiatric hospitals: results of the pharmacoepidemiologic CATS study. Soc Psychiatry Psychiatr Epidemiol. 2013;48:1283–8.CrossRefPubMed
18.
go back to reference Ware J. JR, Kosinski M, Keller SD: a 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34:220–33.CrossRefPubMed Ware J. JR, Kosinski M, Keller SD: a 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34:220–33.CrossRefPubMed
19.
go back to reference Goetz C, Coste J, Lemetayer F, Rat A, Montel S, Recchia S, Debouverie M, Pouchot J, Spitz E, Guillemin F. Item reduction based on rigorous methodological guidelines is necessary to maintain validity when shortening composite measurement scales. J Clin Epidemiol. 2013;66:710–8.CrossRefPubMed Goetz C, Coste J, Lemetayer F, Rat A, Montel S, Recchia S, Debouverie M, Pouchot J, Spitz E, Guillemin F. Item reduction based on rigorous methodological guidelines is necessary to maintain validity when shortening composite measurement scales. J Clin Epidemiol. 2013;66:710–8.CrossRefPubMed
20.
go back to reference Smith GT, McCarthy DM, Anderson KG. On the sins of short-form development. Psychol Assess. 2000;12:102–11.CrossRefPubMed Smith GT, McCarthy DM, Anderson KG. On the sins of short-form development. Psychol Assess. 2000;12:102–11.CrossRefPubMed
21.
go back to reference Tabachnick BG, Fidell LS. Using multivariate statistics. 6th ed. Harlow: Pearson Education Limited; 2014. Tabachnick BG, Fidell LS. Using multivariate statistics. 6th ed. Harlow: Pearson Education Limited; 2014.
22.
go back to reference Kline RB. Principles and practice of structural equation modeling. 3rd ed. New York: Guilford Press; 2011. Kline RB. Principles and practice of structural equation modeling. 3rd ed. New York: Guilford Press; 2011.
23.
go back to reference Hair JF, Black WC, Babin BJ, Anderson RE. Multivariate data analysis: a global perspective. 7th ed. Pearson Prentice Hall: Upper Saddle River, NJ; 2010. Hair JF, Black WC, Babin BJ, Anderson RE. Multivariate data analysis: a global perspective. 7th ed. Pearson Prentice Hall: Upper Saddle River, NJ; 2010.
24.
25.
go back to reference Reddy LF, Llerena K, Kern RS. Predictors of employment in schizophrenia: the importance of intrinsic and extrinsic motivation. Schizophr Res. 2016;176:462–6.CrossRefPubMed Reddy LF, Llerena K, Kern RS. Predictors of employment in schizophrenia: the importance of intrinsic and extrinsic motivation. Schizophr Res. 2016;176:462–6.CrossRefPubMed
26.
go back to reference Bilker WB, Brensinger C, Kurtz MM, Kohler C, Gur RC, Siegel SJ, Gur RE. Development of an abbreviated schizophrenia quality of life scale using a new method. Neuropsychopharmacology. 2003;28:773–7.CrossRefPubMed Bilker WB, Brensinger C, Kurtz MM, Kohler C, Gur RC, Siegel SJ, Gur RE. Development of an abbreviated schizophrenia quality of life scale using a new method. Neuropsychopharmacology. 2003;28:773–7.CrossRefPubMed
27.
go back to reference Ware JE. Improvements in short-form measures of health status: introduction to a series. J Clin Epidemiol. 2008;61:1–5.CrossRefPubMed Ware JE. Improvements in short-form measures of health status: introduction to a series. J Clin Epidemiol. 2008;61:1–5.CrossRefPubMed
Metadata
Title
QLiS-SF: Development of a short form of the quality of life in schizophrenia questionnaire
Authors
T. Senin
M. Franz
M. Deuschle
N. Bergemann
J. Kammerer-Ciernioch
M. Lautenschlager
T. Meyer
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Psychiatry / Issue 1/2017
Electronic ISSN: 1471-244X
DOI
https://doi.org/10.1186/s12888-017-1307-1

Other articles of this Issue 1/2017

BMC Psychiatry 1/2017 Go to the issue